Viral Seroprevalence and Risk of Reactivation in MS Patients Treated With Ocrelizumab: A Real-World Cohort Study

Zengin, ElaSimsek, YaseminCaliskan, CanOzakbas, Serkan2025-12-302025-12-3020251352-45851477-0970https://hdl.handle.net/20.500.14365/8504eninfo:eu-repo/semantics/closedAccessViral Seroprevalence and Risk of Reactivation in MS Patients Treated With Ocrelizumab: A Real-World Cohort StudyConference Object